Skip to main content

Table 1 Distribution of the clinical parameters

From: DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population

Clinical parameters   Distribution (%)
Age (years) 20 to 40 2.30
41 to 60 31.70
61 to >80 66.10
Breast cancer diagnosis Right breast 47.10
Left breast 46.10
Both 6.80
Histology Ductal 67.40
Lobular 15.40
DCIS 6.40
LCIS 1.80
Mixed and other tumor types 9.00
TNM stage I 36.70
IIa 24.40
IIb 10.90
IIIa 8.60
IIIb 5.00
IIIc 8.10
IV 6.30
ER status Positive 82.40
Negative 17.60
PR status Positive 72.40
Negative 27.60
HER2 status Positive 14.00
Negative 67.00
Not defined 19.00
Response of chemotherapy No chemotherapy/data 48.00
Complete remission 32.10
Recurrence 5.90
Stable disease 8.10
Progress 5.90
Survival Not detected 10.90
Alive 76.00
Death 13.10
  1. DCIS, ductal carcinoma in situ; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; LCIS, lobular carcinoma in situ; PR, progesterone receptor; TNM, TNM Classification of Malignant Tumours.